[2 year experience of clonazepam in childhood cerebral spasm seizures].
D000284:Administration, Oral; D000293:Adolescent; D000367:Age Factors; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002722:Chlorobenzenes / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008607:Intellectual Disability; D008297:Male; D009574:Nitro Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000927:Anticonvulsants; D001570:Benzodiazepinones; D002722:Chlorobenzenes; D009574:Nitro Compounds
Zwei Jahre Erfahrungen mit Clonazepam bei zerebralen Krampfanfällen im Kindesalter.